Maternal and reproductive health remain global priorities, with preventable conditions such as postpartum haemorrhage, pre-eclampsia, anaemia, and cervical and breast cancers contributing to significant maternal mortality. Early detection, screening, monitoring, and timely intervention are critical to saving lives, particularly in low-resource settings where access to quality-assured medical devices and frontline healthcare services is limited. UNFPA is therefore seeking Expressions of Interest from wholesalers and manufacturers of medical devices that strengthen maternal and reproductive health care, support early diagnosis, and enable timely, life-saving interventions. The scope includes: Lot 1: Portable and AI-Enabled Point-of-Care Ultrasound (POCUS) Item 1: Portable/Handheld Ultrasound (POCUS) for Maternal Health Lot 2: HPV Detection and Cervical Cancer Screening Item 1: HPV DNA Testing (including self-collection) Item 2: AI-Enabled Cervical Cancer Screening Device (Video Colposcope) Item 3: Portable or Smartphone-Enabled Colposcopy Device Lot 3: Breast Cancer Screening Item 1: Thermal Breast Patch Lot 4: Pre-Eclampsia Detection and Monitoring Item 1: Pre-Eclampsia Detection and Monitoring System (Ambulatory BP Monitor) Item 2: Smartphone Applications for Blood Pressure Monitoring Item 3: Handheld Blood Pressure Monitoring Device Lot 5: Point-of-Care Diagnostic Tests and NCD Management for Maternal Health Item 1: Early Ectopic Pregnancy Detection Diagnostic Kit Item 2: Triple Elimination Diagnostic Rapid Test (HIV, HBV, Syphilis) Item 3: Glucose Monitoring Devices (Continuous Glucose Monitoring Systems) Lot 6: Anaemia Detection and Postpartum Haemorrhage (PPH) Prevention and Management Item 1: Calibrated Drapes (including biodegradable) Item 2: Point-of-Care Haemoglobin Test with Mobile Application